Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic T Moore

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
The American Journal of Dermatopathology|November 23, 2007
Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulcerationRuth Fulghum Walters, Pamela A Groben, Klaus Busam, et al.
Chest|February 4, 2009
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera, Frank C Detterbeck, Mark A Socinski, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 13, 2019
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancerHanna K Sanoff, Dominic H Moon, Dominic T Moore, et al.
Plastic and Reconstructive Surgery|December 28, 2016
Cancer Risk after Fat Transfer: A Multicenter Case-Cohort StudyTerence M Myckatyn, I Janelle Wagner, Babak J Mehrara, et al.
Transplantation and Cellular Therapy|September 2, 2021
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous LeukemiaNicholas P Tschernia, Vaibhav Kumar, Dominic T Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinomaBert H O'Neil, Laura W Goff, John Sae Wook Kauh, et al.
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
Clinical Breast Cancer|November 21, 2017
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast CancerAutumn J McRee, Paul K Marcom, Dominic T Moore, et al.
American Journal of Hematology|January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemiaDaniel R Richardson, David M Swoboda, Dominic T Moore, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
The American Journal of Dermatopathology|November 23, 2007
Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulcerationRuth Fulghum Walters, Pamela A Groben, Klaus Busam, et al.
Chest|February 4, 2009
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera, Frank C Detterbeck, Mark A Socinski, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 13, 2019
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancerHanna K Sanoff, Dominic H Moon, Dominic T Moore, et al.
Plastic and Reconstructive Surgery|December 28, 2016
Cancer Risk after Fat Transfer: A Multicenter Case-Cohort StudyTerence M Myckatyn, I Janelle Wagner, Babak J Mehrara, et al.
Transplantation and Cellular Therapy|September 2, 2021
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous LeukemiaNicholas P Tschernia, Vaibhav Kumar, Dominic T Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinomaBert H O'Neil, Laura W Goff, John Sae Wook Kauh, et al.
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
Clinical Breast Cancer|November 21, 2017
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast CancerAutumn J McRee, Paul K Marcom, Dominic T Moore, et al.
American Journal of Hematology|January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemiaDaniel R Richardson, David M Swoboda, Dominic T Moore, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Pageof 11